Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Change in Accured Expenses (2020 - 2025)

Bio Essence (BIOE) has 6 years of Change in Accured Expenses data on record, last reported at -$334997.0 in Q3 2025.

  • For Q3 2025, Change in Accured Expenses fell 269.76% year-over-year to -$334997.0; the TTM value through Sep 2025 reached -$333162.0, down 280.54%, while the annual FY2024 figure was $200437.0, 1687.62% up from the prior year.
  • Change in Accured Expenses reached -$334997.0 in Q3 2025 per BIOE's latest filing, down from $1.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $301608.0 in Q4 2021 and bottomed at -$490796.0 in Q2 2021.
  • Average Change in Accured Expenses over 5 years is -$19312.5, with a median of -$17.0 recorded in 2023.
  • Peak YoY movement for Change in Accured Expenses: soared 5180.49% in 2024, then crashed 7155.56% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at $301608.0 in 2021, then plummeted by 98.63% to $4129.0 in 2022, then plummeted by 409.08% to -$12762.0 in 2023, then soared by 124.6% to $3140.0 in 2024, then tumbled by 10768.69% to -$334997.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Accured Expenses were -$334997.0 in Q3 2025, $1.0 in Q2 2025, and -$1306.0 in Q1 2025.